Baxter, which makes around 60% of the IV solutions used in the US daily, announced that it has restarted its ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Gifting allows recipients to access the article for free. As production at a key medical supply plant owned by Baxter International remains paused, the federal government is helping the company ...

Since the North Cove plant went offline, hospitals across the country have faced disruption in the supply ... Medical Care ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Baxter International has reduced its dividend by 41% ahead of the medical-products maker's planned $3.8 billion sale of its kidney-care segment to Carlyle Group. Baxter late Monday said its board ...

Baxter expects to lose out on at least $200 million worth of sales due to Hurricane Helene's flooding at its North Cove ...

Baxter International cut its full-year profit forecast as it continues to wrestle with the shutdown of a North Carolina ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and ...

The largest maker of intravenous fluids in the U.S. is struggling to restore deliveries of the crucial medical product ... steps to conserve tight supplies. Baxter International said it expects ...